台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    65.0
  • 漲跌
    ▼2.3
  • 漲幅
    -3.42%
  • 成交量
    434
  • 產業
    上櫃 生技醫療類股
  • 73人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-元大-沙鹿 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-沙鹿 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/0700.00166.0065.90-1481-0.21%
2025/04/2200.003555.3355.50-35471-7.43%
2025/04/11159.5000.0059.2014930.20%
2025/04/0900.00151.7051.20-1491-0.20%
2025/04/02366.7000.0066.6035050.59%
2025/03/1200.00278.4077.50-2585-0.34%
2025/03/113882.90178.5081.50375576.63%
2025/03/10176.00271.5076.80-1518-0.19%
2025/03/07272.4500.0069.9024960.40%
2025/03/0500.00169.0068.90-1484-0.21%
2025/02/2400.00267.0068.00-2504-0.40%
2025/02/21270.20370.0367.80-1508-0.20%
2025/02/20169.30369.5071.00-2497-0.40%
2025/02/19365.5700.0065.5034900.61%
2025/02/1700.00461.6062.20-4521-0.77%
2025/02/11463.6500.0064.0045940.67%
2025/02/0700.00260.7060.80-2589-0.34%
2025/02/0600.00160.7060.60-1600-0.17%
2025/01/1700.00158.6058.60-1616-0.16%
2025/01/15362.2000.0061.0036160.49%
2025/01/13264.2500.0062.8026270.32%
2024/12/30264.9000.0066.7026920.29%
2024/12/2400.000.373.0073.00-0.3677-0.04%
2024/12/2000.00161.9060.40-1684-0.15%
2024/12/19162.9000.0062.7016950.14%
2024/12/1200.00155.9054.90-1678-0.15%
2024/12/11155.0000.0054.9016660.15%
2024/12/0900.00163.0062.00-1646-0.15%
2024/12/04066.5000.0067.0006550.00%
2024/11/22173.5000.0073.0016720.15%
2024/11/130.264.11764.4164.00-6.8652-1.04%
2024/11/12064.30367.3070.00-3632-0.47%
2024/11/11170.1000.0070.1016060.16%
2024/11/08179.99480.5877.80-3603-0.49%
2024/10/30193.8000.0093.8016700.15%
2024/10/28096.6800.0095.5006880.00%
2024/10/180112.0000.00110.0007680.00%
2024/10/161117.0000.00117.0017990.13%
2024/10/150120.0000.00117.0008110.00%
2024/10/141122.0000.00121.0018170.12%
2024/10/1100.002117.75114.50-2824-0.24%
2024/10/096122.0800.00119.0068380.72%
2024/10/072116.5000.00116.5028300.24%
2024/10/0400.004106.50106.50-4813-0.49%
2024/10/01197.2000.0097.2017870.13%
2024/09/241156.001168.00159.0007890.00%
2024/09/231162.0000.00158.0017940.13%
2024/09/0300.000.1222.00217.00-0.1797-0.02%
2024/09/020.1227.0000.00222.500.17980.02%
2024/08/3000.001217.00216.00-1792-0.13%
2024/08/291223.0000.00221.0017950.13%
2024/08/2600.001228.50226.00-1790-0.13%
2024/08/231227.0000.00229.0017980.13%
2024/08/2200.001222.00221.50-1798-0.13%
2024/08/2000.001217.50216.00-1806-0.12%
2024/08/1900.001203.00201.50-1820-0.12%
2024/08/1600.001200.00200.50-1822-0.12%
2024/08/1300.001192.50189.00-1843-0.12%
2024/08/121202.5000.00198.0018350.12%
2024/08/091180.0000.00203.5018240.12%
2024/08/0800.002185.50187.00-2794-0.25%
2024/08/061180.0000.00171.0017770.13%
2024/08/0100.000.1168.50175.50-0.1732-0.01%
2024/07/310.1159.5000.00161.000.17270.01%
2024/07/3000.000144.83148.0007160.00%
2024/07/2300.002161.00160.00-2685-0.29%
2024/07/222175.7500.00164.0026670.30%
2024/07/192184.5000.00182.0026500.31%
2024/07/181197.000185.00196.5016110.16%
2024/07/170190.5000.00191.0005890.00%
2024/07/1100.000152.00149.0005310.00%
2024/07/100146.500.1151.00152.50-0.1512-0.01%
2024/07/080136.5000.00138.5004930.01%
2024/07/0200.001138.00138.00-1446-0.22%
2024/07/011.1137.6100.00137.501.14350.24%
2024/06/1700.000.5108.00108.00-0.5353-0.14%
2024/06/1100.001102.51101.50-1324-0.31%
2024/06/05096.0000.0098.6003150.01%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音